People born 1947-1951 invited for COVID-19 vaccination starting 6 April Starting Tuesday 6 April, the first people in the next age group will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1947 through 1951.
Single vaccination after COVID-19 infection within the past six months Starting today, people who tested positive for COVID-19 in the past six months can indicate when scheduling a vaccination appointment that they only want one vaccine dose.
State Secretary Blokhuis: boys will also be vaccinated against HPV virus The vaccine against the HPV human papillomavirus virus will also become available for boys.
A guide for the safe reuse of diaper and incontinence materials RIVM has developed a step-by-step plan for the safe reuse of diapers and incontinence material. This plan provides recyclers and licensing authorities with tools to carry out a risk assessment.
New data on greenhouse gas and ammonia emissions Greenhouse gas emissions have fallen slightly; ammonia emissions remain stable.
Humans themselves are the most important source of ESBL Antibiotic Resistance Human to human transfer is the main source of ESBL (Extended Spectrum Beta-Lactamase) antibiotic resistance, according to researchers from the ESBLAT research consortium, of which RIVM is a member.
Medication may affect diagnostic tests The use of medication may affect diagnostic tests. This may distort the results of those tests.
Mild 2018-2019 influenza epidemic The annual influenza epidemic in the winter of 2018-2019 was less severe than the year before. Approximately 400,000 people have had the flu.
Construction officially starts on new accommodations for VWS / RIVM and CBG Hugo de Jonge, Dutch Minister of Health, Welfare and Sport, marked the official start of construction on the new accommodations for RIVM and for the Medicines Evaluation Board (CBG).
A critical look at the European Union Observatory for Nanomaterials On 14 June 2017, the European Commission launched the “European Union Observatory for Nanomaterials” (EUON). As registration is not mandatory, the EUON is limited in detailed information.